Product Images Tivdak

TIVDAK is a prescription medicine used to treat certain types of cancer. It is a hazardous agent and must be reconstituted and diluted before intravenous infusion. Each vial contains 40mg of tisotumab vedotin-tftv, and after reconstitution with sterile water, the concentration is 10mg/mL. TIVDAK must be kept refrigerated between 2°C and 8°C and must not be frozen or shaken. Any unused portion of the solution must be discarded, and each patient must be provided with the enclosed Medication Guide. For more information, contact Seagen Inc. at 1-855-4SEAGEN.*

This is a description of Tivdaks, a hazardous agent that can only be used for intravenous infusion after reconstitution and dilution. It is stored between 2°C to 8°C (36°F to 46°F) and is a single-dose vial. The unused portion must be discarded. Tivdaks should not be frozen or shaken, and dosage should be determined by the prescribing information provided. Each patient should be given an enclosed medication guide. It is manufactured by Seagen Inc. in the US, licensed with 2257, and is a product of Switzerland. The lot and expiration number are not given.*

This is a not-available response as the given text consists of only chemical names and formulas, without any context or description of their purpose or use.*